Cornerstone Planning Group »

Reneo Pharmaceuticals shares owned by Cornerstone Planning Group

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Cornerstone Planning Group from 13F filings

Historical chart of Cornerstone Planning Group investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Cornerstone Planning Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Cornerstone Planning Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $946 53 17.87

More positions owned by Cornerstone Planning Group

Invesco Qqq Trust Series I Exchange Traded Fund (QQQ)
Vanguard Ftse Developed Markets Etf Exchange Traded Fund (VEA)
Schwab Fundamental U.s. Large Company Etf Exchange Traded Fund (FNDX)
Ishares U.s. Smallcap Equity Factor Etf Exchange Traded Fund (SMLF)
Ishares Morningstar Mid-cap Growth Etf Exchange Traded Fund (IMCG)
Vanguard Intermediate-term Bond Etf Exchange Traded Fund (BIV)
Ishares High Yield Systematic Bond Etf Exchange Traded Fund (HYDB)
Ishares Convertible Bond Etf Exchange Traded Fund (ICVT)
Victoryshares Short-term Bond Etf Exchange Traded Fund (USTB)
Ishares Residential And Multisector Real Estate Etf Exchange Traded Fund (REZ)
First Trust Long/short Equity Etf Exchange Traded Fund (FTLS)
First Trust Emerging Markets Small Cap Alphadex Fund Exchange Traded Fund (FEMS)
Pacer Us Cash Cows 100 Etf Exchange Traded Fund (COWZ)
First Trust Materials Alphadex Fund Exchange Traded Fund (FXZ)
Schwab Us Dividend Equity Etf Exchange Traded Fund (SCHD)

View all positions for Cornerstone Planning Group

Top funds holding Reneo Pharmaceuticals

NEA Management Company
BML Capital Management
Highbridge Capital Management
Tang Capital Management
Carlyle
RiverVest Venture Management
Octagon Capital Advisors
Ikarian Capital
Aisling Capital Management
Vanguard Group
Vestal Point Capital
Nantahala Capital Management
Renaissance Technologies
Aldebaran Capital
Acuitas Investments

View all funds holding Reneo Pharmaceuticals